Familial Pfeiffer Syndrome: Variable Manifestations and Role of Multidisciplinary Team Care

Sarut Chaisrisawadisuk1,2, Mark H Moore1

  • 1Cleft and Craniofacial South Australia, Women's and Children's Hospital, North Adelaide, South Australia, Australia.

Insights

Pfeiffer syndrome, an autosomal dominant disorder, presents with varied symptoms. This study details a family with an FGFR1 mutation showing reduced cranial involvement in younger generations, suggesting variable expressivity.

Area of Science:

  • Genetics
  • Craniofacial Biology
  • Medical Genetics

Background:

  • Pfeiffer syndrome is an autosomal dominant craniofacial disorder characterized by coronal suture synostosis, midface retrusion, and limb abnormalities.
  • Type I Pfeiffer syndrome is typically linked to mutations in the Fibroblast Growth Factor Receptor 1 (FGFR1) gene.
  • Clinical manifestations can be highly variable, even within families, and may not always include craniosynostosis.

Purpose of the Study:

  • To investigate the genetic basis and clinical spectrum of Pfeiffer syndrome in a multi-generational family.
  • To analyze the impact of a specific FGFR1 mutation (c.755C>G, p.Pro252Arg) on phenotypic expression across generations.
  • To propose a management guideline for familial Pfeiffer syndrome.

Main Methods:

  • Clinical evaluation of affected family members across three generations.
  • Genetic analysis to identify and confirm the specific FGFR1 mutation.
  • Phenotypic correlation between genotype and clinical manifestations, focusing on cranial involvement.

Main Results:

  • Identified an identical FGFR1: c.755C>G (p.Pro252Arg) mutation in all affected family members across three generations.
  • Observed a significant reduction in cranial involvement, specifically craniosynostosis, in the youngest generation.
  • Demonstrated variable expressivity of Pfeiffer syndrome, with the same mutation leading to different clinical presentations.

Conclusions:

  • The FGFR1: c.755C>G (p.Pro252Arg) mutation is causative for Pfeiffer syndrome in this family.
  • Phenotypic variability, including the absence of cranial involvement in some individuals, is a key feature.
  • A structured management guideline is proposed for familial Pfeiffer syndrome, considering genotype-phenotype correlations.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
86
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
151
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
78
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
282
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
103
Interdisciplinary Care: The Health Care Team-II01:18

Interdisciplinary Care: The Health Care Team-II

An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care. Here are a few more healthcare professionals.
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
1.6K